BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29547736)

  • 21. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Adachi S; Kase H; Motoyama T; Inoue I; Enomoto T
    Hum Reprod; 2019 Oct; 34(10):1899-1905. PubMed ID: 31621846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma.
    Zannoni GF; Improta G; Chiarello G; Pettinato A; Petrillo M; Scollo P; Scambia G; Fraggetta F
    Virchows Arch; 2014 Aug; 465(2):193-8. PubMed ID: 24889043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (Partial) Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes.
    Borrelli GM; Abrão MS; Taube ET; Darb-Esfahani S; Köhler C; Chiantera V; Mechsner S
    Mol Hum Reprod; 2016 May; 22(5):329-37. PubMed ID: 26832958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis.
    Vestergaard AL; Thorup K; Knudsen UB; Munk T; Rosbach H; Poulsen JB; Guldberg P; Martensen PM
    Mol Hum Reprod; 2011 Dec; 17(12):758-61. PubMed ID: 21724579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PIK3CA, HRAS and KRAS gene mutations in human penile cancer.
    Andersson P; Kolaric A; Windahl T; Kirrander P; Söderkvist P; Karlsson MG
    J Urol; 2008 May; 179(5):2030-4. PubMed ID: 18355852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
    Kim SI; Lee JW; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS
    Gynecol Oncol; 2018 Feb; 148(2):375-382. PubMed ID: 29233531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis.
    Suda K; Cruz Diaz LA; Yoshihara K; Nakaoka H; Yachida N; Motoyama T; Inoue I; Enomoto T
    Cancer Sci; 2020 Aug; 111(8):3000-3009. PubMed ID: 32473611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout mice.
    Ono M; Miyamoto T; Asaka R; Uchikawa J; Ando H; Tanaka Y; Shinagawa M; Yokokawa Y; Asaka S; Wang TL; Shih IM; Shiozawa T
    Sci Rep; 2023 May; 13(1):8348. PubMed ID: 37221199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients.
    Nagasawa S; Ikeda K; Horie-Inoue K; Sato S; Takeda S; Hasegawa K; Inoue S
    Endocr J; 2020 Feb; 67(2):219-229. PubMed ID: 31748433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.
    Zannoni GF; Improta G; Pettinato A; Brunelli C; Troncone G; Scambia G; Fraggetta F
    J Clin Pathol; 2016 Dec; 69(12):1088-1092. PubMed ID: 27153872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
    Ta TV; Nguyen QN; Chu HH; Truong VL; Vuong LD
    Pathol Res Pract; 2020 Apr; 216(4):152898. PubMed ID: 32089414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel MYH8 mutations in 152 Han Chinese samples with ovarian endometriosis.
    Lou J; Zou Y; Luo Y; Zhang ZY; Liu FY; Tan J; Zeng X; Wan L; Huang OP
    Gynecol Endocrinol; 2020 Jul; 36(7):632-635. PubMed ID: 32308057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.
    Maeda D; Shih IeM
    Adv Anat Pathol; 2013 Jan; 20(1):45-52. PubMed ID: 23232571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.
    Zhang J; Zheng J; Yang Y; Lu J; Gao J; Lu T; Sun J; Jiang H; Zhu Y; Zheng Y; Liang Z; Liu T
    Sci Rep; 2015 Dec; 5():18678. PubMed ID: 26691448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients.
    Guo F; Gong H; Zhao H; Chen J; Zhang Y; Zhang L; Shi X; Zhang A; Jin H; Zhang J; He Y
    Sci Rep; 2018 Apr; 8(1):6076. PubMed ID: 29666387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
    Wiegand KC; Hennessy BT; Leung S; Wang Y; Ju Z; McGahren M; Kalloger SE; Finlayson S; Stemke-Hale K; Lu Y; Zhang F; Anglesio MS; Gilks B; Mills GB; Huntsman DG; Carey MS
    BMC Cancer; 2014 Feb; 14():120. PubMed ID: 24559118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial Mutations in Endometriosis: Link to Ovarian Cancer.
    Bulun SE; Wan Y; Matei D
    Endocrinology; 2019 Mar; 160(3):626-638. PubMed ID: 30657901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
    Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
    Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis.
    Stewart CJ; Leung Y; Walsh MD; Walters RJ; Young JP; Buchanan DD
    Hum Pathol; 2012 Aug; 43(8):1177-83. PubMed ID: 22305241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.
    Anglesio MS; Bashashati A; Wang YK; Senz J; Ha G; Yang W; Aniba MR; Prentice LM; Farahani H; Li Chang H; Karnezis AN; Marra MA; Yong PJ; Hirst M; Gilks B; Shah SP; Huntsman DG
    J Pathol; 2015 Jun; 236(2):201-9. PubMed ID: 25692284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.